Xiaojian Yao's Lab
@uom_yaoslab1
Retroviorology, Medical Microbiology, HIV, influenza, SARS-Cov-2, Vaccine, Ebola virus
ID: 1551620725542248449
25-07-2022 17:30:09
35 Tweet
190 Takipçi
93 Takip Edilen
ncbi.nlm.nih.gov/pmc/articles/P… A recombinant VSV-based bivalent vaccine effectively protects against Both SARS-COV-2 and Influenza virus infection... Research Manitoba CIHR Pfizer Inc. Moderna